Clin Asst Prof Soh Shui Boon

Dr Soh Shui Boon is a Senior Consultant with the Department of Endocrinology at Changi General Hospital (CGH).

Dr Soh obtained her MBBS from National University of Singapore (NUS) in 2002 and became a member of the Royal College of Physicians of the United Kingdom in 2007. She subsequently completed postgraduate specialty training in endocrinology in Singapore and went on to do did a one-year sabbatical in The Alfred Hospital, Melbourne from 2012 to 2013 to pursue her interest in thyroid diseases.  

Dr Soh also has a keen interest in medical education, and completed her Masters of Medical Education at University of Dundee in 2026 with distinction. She plays an active role in both undergraduate and postgraduate medical education and has won several SingHealth Residency Outstanding Faculty Awards over the years.

• MMedEd (Distinction), UK, 2026
• Fellowship in Thyroid Diseases, Australia, 2012-2013
• Specialist Accreditation in Endocrinology, Singapore, 2011
• MRCP, UK, 2007
• MBBS, Singapore, 2002

• Senior Clinical Lecturer, NUS Yong Loo Lin School of Medicine
• Associate Program Director, SingHealth Advanced Internal Medicine Residency Program
• Core Faculty Member, SingHealth Endocrinology Senior Residency Program
• Physician Faculty Member, SingHealth PGY1 Residency Program
• Physician Faculty Member and Mentor, SingHealth Internal Medicine Residency Program

• Singapore Medical Journal Reviewer Recognition Award, 2025
• Outstanding Faculty Award, Residency in SingHealth Excels (RiSE), 2023, 2022, 2019, 2017
• Star, SingHealth Health Quality Service Award, 2024
• Silver, SingHealth Health Quality Service Award, 2023
• OneCGHCares Award, CGH, 2022
• Gold, SingHealth Health Quality Service Award, 2018
• Silver, Eastern Health Alliance Caring Award, 2017
• HMDP Fellowship Award on Advanced Multi-disciplinary Management and Research in Thyroid Disease, The Alfred Hospital (Melbourne), 2012-2013

• Effects of 4-month therapy of levothyroxine on non-alcoholic fatty liver disease (NAFLD) and diabetes control in diabetic male patients (Site PI; completed)
• A 24-week multicentre, randomized, double-blinded, placebo-controlled, parallel-group, phase 3 trial to evaluate the efficacy and safety of Dapagliflozin added to the therapy of Asian subjects with type 2 diabetes who have inadequate glycemic control on insulin (Site Co-I; completed)
• Prospective diabetes registry of patients with type 2 diabetes mellitus on SGLT2 inhibitor therapy in Singapore (Site Co-I; ongoing) • EDEN study - ELO water in diabetes care for enhancement of blood glucose control (Site Co-I; ongoing)
• PACES PA study - Prospective study assessing blood pressure, cardiovascular, endothelial and other outcomes post surgical and medical treatment in patients with primary aldosteronism (Co-I; ongoing)

• Jielin Yew, Shui-Boon Soh, An atypical presentation of primary hyperparathyroidism with multiple spontaneous tendon ruptures: a case report and literature review on management of primary hyperparathyroidism, Journal of the ASEAN Federation of Endocrine Societies (JAFES) Nov 2022. Vol 31, No. 2: 76-82.

• Sarah Tan, Jiaqing Xiong, Joan Khoo, Troy Puar, Andy Wong, Shui-Boon Soh, Acute flaccid tetraparesis in COVID-19 infection: think of the thyroid, Case Reports in Medicine. Vol 2022. Article ID 5827664. Published 29 Apr 2022

• Chiaw Ling Chng, Shui-Boon Soh, Jielin Yew et al, The application of ThyPRO questionnaire in patients with Graves’ disease treated with anti-thyroid medications, Journal of the Endocrine Society vol 5 supplement_1 Apr-May 2021, A833-834

• Shui-Boon Soh, Tar-Choon Aw, Laboratory testing in thyroid conditions: pitfalls and utilities, Annals of Laboratory Medicine. Jan 2019; Volume 39; Number 1: 3-14

• E Bruinstroop, R Dalan, Cao Yang, YM Bee, K Chandran, LW Cho, CF Sum, HH Tan, EK Teo, SA Toh, Shui-Boon Soh, MKS Leow, SC Lim, RA Sinha, SA Sadananthan, N Michael, QS Lu, SS Velan, PM Yen, Low dose Levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD, J Clin Endo Metab. Jul 2018; 103(7): 2698-2706

• Shui-Boon Soh, Duncan J Topliss, Classification and Laboratory Diagnosis of Diabetes Mellitus, Francisco Bandeira, Hossein Gharib, Airton Golbert, Luiz Griz, Manuel Faria in Endocrinology and Diabetes – a Problem-Oriented Approach, Springer, New York. 1, 347-359

• Shui-Boon Soh, Alan Pham, Robyn E O’Hehir, Martin Cherk, Duncan J Topliss, Novel Use of Rituximab in a case of Riedel’s Thyroiditis refractory to Glucocorticoids and Tamoxifen, J Clin Endo Metab. Sept 2013; 98(9): 3543-49

• Duncan J Topliss, Shui-Boon Soh, Use and Misuse of Thyroid Hormone, Singapore Medical Journal. Jul 2013; 54(7): 406-10

• Shui-Boon Soh, Duncan J Topliss, Thyroid dysfunction in pregnancy: optimising obstetric outcomes, Endocrinology Today. Apr 2013; 2(2): 8-16